Last reviewed · How we verify
Midazolam , Rosuvastatin calcium and digoxin
Midazolam , Rosuvastatin calcium and digoxin is a Small molecule drug developed by Allist Pharmaceuticals, Inc.. It is currently in Phase 1 development.
At a glance
| Generic name | Midazolam , Rosuvastatin calcium and digoxin |
|---|---|
| Sponsor | Allist Pharmaceuticals, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) (PHASE3)
- Phase 1, Open-label, Drug-drug Interaction Study to Assess Effect Between Radiprodil and the Co-administered Drugs. (PHASE1)
- A Research Study of the Effect of Etavopivat on Other Drugs in Healthy Participants (PHASE1)
- A Phase 1 Clinical Study to Evaluate the Effects of SHR7280 on the Pharmacokinetics of Midazolam, S-warfarin, Omeprazole, Digoxin, and Rosuvastatin in Healthy Subjects (PHASE1)
- A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone (PHASE1)
- VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI) (PHASE1)
- A Clinical Trial to Evaluate JAB-21822 Drug-drug Interactions in Healthy Subjects (PHASE1)
- A Drug-drug Interaction Study Evaluating the Perpetrator Potential of LY4100511 (DC-853) on Midazolam, Repaglinide, Digoxin, Rosuvastatin in Healthy Participants (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Midazolam , Rosuvastatin calcium and digoxin CI brief — competitive landscape report
- Midazolam , Rosuvastatin calcium and digoxin updates RSS · CI watch RSS
- Allist Pharmaceuticals, Inc. portfolio CI
Frequently asked questions about Midazolam , Rosuvastatin calcium and digoxin
What is Midazolam , Rosuvastatin calcium and digoxin?
Midazolam , Rosuvastatin calcium and digoxin is a Small molecule drug developed by Allist Pharmaceuticals, Inc..
Who makes Midazolam , Rosuvastatin calcium and digoxin?
Midazolam , Rosuvastatin calcium and digoxin is developed by Allist Pharmaceuticals, Inc. (see full Allist Pharmaceuticals, Inc. pipeline at /company/allist-pharmaceuticals-inc).
What development phase is Midazolam , Rosuvastatin calcium and digoxin in?
Midazolam , Rosuvastatin calcium and digoxin is in Phase 1.